These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21737124)

  • 1. Plasma factor VII-activating protease is increased by oral contraceptives and induces factor VII activation in-vivo.
    Sidelmann JJ; Skouby SO; Kluft C; Winkler U; Vitzthum F; Schwarz H; Gram J; Jespersen J
    Thromb Res; 2011 Nov; 128(5):e67-72. PubMed ID: 21737124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VII-activating protease in patients with acute deep venous thrombosis.
    Sidelmann JJ; Vitzthum F; Funding E; Münster AM; Gram J; Jespersen J
    Thromb Res; 2008; 122(6):848-53. PubMed ID: 18394684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
    Etscheid M; Muhl L; Pons D; Jukema JW; König H; Kanse SM
    Thromb Res; 2012 Dec; 130(6):935-41. PubMed ID: 22906531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women.
    Sidelmann JJ; Skouby SO; Vitzthum F; Schwarz H; Jespersen J
    Climacteric; 2010 Aug; 13(4):340-6. PubMed ID: 20222844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor seven ativating potease (FSAP) levels during normal pregnancy and in women using oral contraceptives.
    Parahuleva MS; Hölschermann H; Erdogan A; Langanke E; Prickartz I; Parviz B; Weiskirchen R; Tillmanns H; Kanse SM
    Thromb Res; 2010 Jul; 126(1):e36-40. PubMed ID: 20381831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative detection of the Marburg I alloenzyme of factor VII-activating protease by an immunoassay and its comparison to PCR testing.
    Schwarz H; Stephan S; Sidelmann JJ; Fischer B; Althaus H; Hahn M; Kappel A; Ehm M; Vitzthum F
    Clin Chem Lab Med; 2010 Dec; 48(12):1745-9. PubMed ID: 20828365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine modulation of factor VII activating protease (FSAP) expression in human monocytes.
    Parahuleva MS; Langanke E; Hölschermann H; Parviz B; Abdallah Y; Stracke S; Tillmanns H; Kanse SM
    J Atheroscler Thromb; 2012; 19(11):962-9. PubMed ID: 22878700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis.
    Kanse SM; Parahuleva M; Muhl L; Kemkes-Matthes B; Sedding D; Preissner KT
    Thromb Haemost; 2008 Feb; 99(2):286-9. PubMed ID: 18278176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tests for the measurement of factor VII-activating protease (FSAP) activity and antigen levels in citrated plasma, their correlation to PCR testing, and utility for the detection of the Marburg I-polymorphism of FSAP.
    Stephan S; Schwarz H; Borchert A; Bussfeld D; Quak E; Simshaeuser-Knaub B; Teigelkamp S; Behrens F; Vitzthum F
    Clin Chem Lab Med; 2008; 46(8):1109-16. PubMed ID: 18605956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor seven activating protease (FSAP): does it activate factor VII?
    Stavenuiter F; Dienava-Verdoold I; Boon-Spijker MG; Brinkman HJ; Meijer AB; Mertens K
    J Thromb Haemost; 2012 May; 10(5):859-66. PubMed ID: 22235940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VII activating protease (FSAP): a novel protease in hemostasis.
    Römisch J
    Biol Chem; 2002; 383(7-8):1119-24. PubMed ID: 12437095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme.
    Kannemeier C; Feussner A; Stöhr HA; Weisse J; Preissner KT; Römisch J
    Eur J Biochem; 2001 Jul; 268(13):3789-96. PubMed ID: 11432747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a.
    Kanse SM; Gallenmueller A; Zeerleder S; Stephan F; Rannou O; Denk S; Etscheid M; Lochnit G; Krueger M; Huber-Lang M
    J Immunol; 2012 Mar; 188(6):2858-65. PubMed ID: 22308306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VII-Activating Protease: Hemostatic Protein or Immune Regulator?
    Zeerleder S
    Semin Thromb Hemost; 2018 Mar; 44(2):151-158. PubMed ID: 29172215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma factor VII-activating protease antigen levels and activity are increased in ischemic stroke.
    Hanson E; Kanse SM; Joshi A; Jood K; Nilsson S; Blomstrand C; Jern C
    J Thromb Haemost; 2012 May; 10(5):848-56. PubMed ID: 22409238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men.
    Borkham-Kamphorst E; Zimmermann HW; Gassler N; Bissels U; Bosio A; Tacke F; Weiskirchen R; Kanse SM
    J Hepatol; 2013 Jan; 58(1):104-11. PubMed ID: 22989567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.